Immunotherapy after bladder cancer surgery may reduce recurrence, study shows ...Middle East

- News
Immunotherapy after bladder cancer surgery may reduce recurrence, study shows
ew research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published in the New England Journal of Medicine.

Hence then, the article about immunotherapy after bladder cancer surgery may reduce recurrence study shows was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy after bladder cancer surgery may reduce recurrence, study shows )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News